XML 53 R36.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Business Segment Information (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2017
Segment Reporting [Abstract] |
Information concerning combined operations by business segment | Information concerning operations of our business segment is presented in the following table (in millions):
| Year Ended December 31,
| 2017 |  | 2016 |  | 2015
Net Sales |  |  |  |  |
Medical Devices | $ | 611.6 |  |  | $ | 566.2 |  |  | $ | 509.0 |
Corporate and Other | — |  |  | — |  |  | — |
Total Net Sales | 611.6 |  |  | 566.2 |  |  | 509.0 |
Operating Profit (Loss) |  |  |  |  |
Medical Devices | 155.2 |  |  | 123.8 |  |  | 107.8 |
Corporate and Other(a)(b)(c) | (178.2 | ) |  | (211.2 | ) |  | (227.3 | )
Other (expense) income, net(d) | (20.1 | ) |  | (19.7 | ) |  | (16.2 | )
Total Operating Loss | (43.1 | ) |  | (107.1 | ) |  | (135.7 | )
Interest income | 2.5 |  |  | 0.6 |  |  | 0.3 |
Interest expense | (31.6 | ) |  | (32.7 | ) |  | (33.1 | )
Loss before Income Taxes | $ | (72.2 | ) |  | $ | (139.2 | ) |  | $ | (168.5 | )
_______________________________________________
(a) | For the year ended December 31, 2017, Corporate and other costs included $116 million, respectively, of costs historically presented as a component of the S&IP business, $55 million of general expenses, $5 million of restructuring costs and $8 million of acquisition-related charges partially offset by a $6 million benefit related to realignment of internal policies for our post-divestiture business.
(b) | For the year ended December 31, 2016, Corporate and other costs included $114 million of costs historically presented as a component of the S&IP business, $66 million of general expenses, $14 million of post spin-related costs $18 million, respectively, of acquisition-related charges.
(c) | For the year ended December 31, 2015, Corporate and other costs included $133 million of costs historically presented as a component of the S&IP business, $49 million of general expenses and $46 million of post spin-related expenses.
(d) | Other expense, net is primarily costs related to litigation and legal matters.
Depreciation, amortization and capital expenditures by segment | Depreciation, amortization and capital expenditures are as follows (in millions):
| Year Ended December 31,
| 2017 |  | 2016 |  | 2015
Depreciation and Amortization |  |  |  |  |
Medical Devices | $ | 27.4 |  |  | $ | 30.4 |  |  | $ | 30.8 |
Corporate and Other(a) | 32.1 |  |  | 34.8 |  |  | 34.6 |
Total Depreciation and Amortization | 59.5 |  |  | 65.2 |  |  | 65.4 |
Capital Expenditures |  |  |  |  |
Medical Devices | $ | 21.9 |  |  | $ | 17.7 |  |  | $ | 23.2 |
Corporate and Other(b) | 21.3 |  |  | 11.4 |  |  | 47.2 |
Total Capital Expenditures | $ | 43.2 |  |  | $ | 29.1 |  |  | $ | 70.4 |
_______________________________________________
(a) | Depreciation and Amortization in Corporate and Other includes depreciation of corporate assets and depreciation and amortization of assets associated with discontinued operations (See “Discontinued Operations” in Note 2).
(b) | Corporate and other capital expenditures includes expenditures for corporate assets and expenditures associated with discontinued operations.
Information concerning assets by business segment | Information concerning assets by business segment is presented in the following table (in millions):
| As of December 31,
| 2017 |  | 2016
Assets |  |  |
Medical Devices | $ | 1,189.6 |  |  | $ | 1,197.2 |
Corporate and Other(a) | 1,006.3 |  |  | 874.6 |
Total Assets | $ | 2,195.9 |  |  | $ | 2,071.8 |
_______________________________________________
(a) | Corporate and other assets includes corporate assets, certain current assets and liabilities associated with discontinued operations that we will retain after closing the Divestiture and assets held for sale.

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599 + Details
Name: | us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration